Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment.

MLA

Raspadori, D., et al. “Long-Lasting Decrease of CD4+/CD45RA+ T Cells in HCL Patients after 2-Chlorodeoxyadenosine (2-CdA) Treatment.” Leukemia (08876924), vol. 13, no. 8, Aug. 1999, pp. 1254–57. EBSCOhost, https://doi.org/10.1038/sj.leu.2401476.

APA

Raspadori, D., Rondelli, D., Birtolo, S., Lenoci, M., Nardi, G., Scalia, G., Sestigiani, C., Tozzi, M., Marotta, G., & Lauria, F. (1999). Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment. Leukemia (08876924), 13(8), 1254–1257. https://doi.org/10.1038/sj.leu.2401476

Chicago

Raspadori, D, D Rondelli, S Birtolo, M Lenoci, G Nardi, G Scalia, C Sestigiani, M Tozzi, G Marotta, and F Lauria. 1999. “Long-Lasting Decrease of CD4+/CD45RA+ T Cells in HCL Patients after 2-Chlorodeoxyadenosine (2-CdA) Treatment.” Leukemia (08876924) 13 (8): 1254–57. doi:10.1038/sj.leu.2401476.